Description

Description

Neoglip 50/500mg is a combination antidiabetic medicine manufactured by ATCO Laboratories, formulated with Sitagliptin and Metformin. It brings together two mechanisms of action to help control blood sugar levels in patients with type 2 diabetes — Sitagliptin enhances the body’s natural insulin response, while Metformin reduces glucose production by the liver and improves insulin sensitivity. Together, they offer more effective blood sugar management than either medicine alone.

Ingredients

Each film-coated tablet of Neoglip contains:

• Sitagliptin – 50mg (a DPP-4 inhibitor)
• Metformin Hydrochloride – 500mg (a biguanide)

Dosage Form

Neoglip 50/500mg is available as oral film-coated tablets, packed 14 tablets per strip/box.

Uses

Neoglip 50/500mg is commonly prescribed for:

• Management of type 2 diabetes mellitus, particularly when blood sugar isn’t adequately controlled on Metformin alone
• Combination therapy for patients requiring both improved insulin response and reduced liver glucose production
• Supporting better glycemic control alongside diet and exercise

How to Use

Neoglip should be taken exactly as directed by a registered physician, typically once or twice daily with meals, to help reduce the risk of stomach upset. Swallow the tablet whole with a glass of water — do not crush or chew it. Your doctor will determine the appropriate dose based on your blood sugar levels and kidney function. Continue to follow your prescribed diet and exercise plan alongside this medicine, and do not stop treatment without consulting your doctor.

Side Effects

Common side effects that may occur with Neoglip include:

• Nausea or stomach upset
• Diarrhea
• Abdominal discomfort
• Headache
• Low blood sugar (hypoglycemia), especially when combined with other diabetes medicines
• Metallic taste in the mouth

Rarely, Metformin-containing medicines may cause a serious condition called lactic acidosis; seek immediate medical attention if you experience unusual muscle pain, difficulty breathing, or extreme tiredness.

Pregnancy & Breastfeeding

Neoglip is generally not recommended during pregnancy, as insulin is usually preferred for managing blood sugar levels in pregnant women with diabetes. It should only be used if a doctor determines it is clearly necessary. Use during breastfeeding should also be discussed with a physician, as safety data for this combination is limited.

Storage Instructions

Store Neoglip tablets below 30°C in a cool, dry place, away from direct sunlight and moisture. Keep the tablets in their original packaging until use, and store them out of reach of children.

FAQs

Q: Can Neoglip be taken instead of insulin?
A: No, it is not a substitute for insulin and is used for type 2 diabetes management under a doctor’s guidance, not type 1 diabetes.

Q: Does Neoglip cause low blood sugar on its own?
A: When used alone, the risk is generally low, but it increases when combined with other diabetes medicines like sulfonylureas or insulin.

Q: How long does it take for Neoglip to control blood sugar?
A: Initial effects may be seen within days, but optimal blood sugar control is typically achieved after several weeks of consistent use.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.